96 related articles for article (PubMed ID: 26587692)
21. The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model.
Ackermann J; Beermann F
Pigment Cell Res; 2005 Aug; 18(4):315-9. PubMed ID: 16029424
[TBL] [Abstract][Full Text] [Related]
22. Carcinogen treatment in mouse selectively expressing activated N-Ras Q61K in melanocytes recapitulates metastatic cutaneous melanoma development.
Contassot E; Jankovic D; Schuler P; Preynat-Seauve O; Gehrke S; Kerl K; Beermann F; French LE
Pigment Cell Melanoma Res; 2012 Mar; 25(2):275-8. PubMed ID: 22128787
[TBL] [Abstract][Full Text] [Related]
23. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
24. Histopathological atlas and proposed classification for melanocytic lesions in Tyr::NRas(Q61K) ; Cdkn2a(-/-) transgenic mice.
Campagne C; Reyes-Gomez E; Battistella M; Bernex F; Château-Joubert S; Huet H; Beermann F; Aubin-Houzelstein G; Egidy G
Pigment Cell Melanoma Res; 2013 Sep; 26(5):735-42. PubMed ID: 23647911
[No Abstract] [Full Text] [Related]
25. Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.
Bartlett D; Boyle GM; Ziman M; Medic S
PLoS One; 2015; 10(4):e0124154. PubMed ID: 25880082
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
Yaman B; Akalin T; Kandiloğlu G
Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
[TBL] [Abstract][Full Text] [Related]
27. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
Larue L; Dougherty N; Bradl M; Mintz B
Oncogene; 1993 Mar; 8(3):523-31. PubMed ID: 8382353
[TBL] [Abstract][Full Text] [Related]
28. Comparative expression analysis of Pax3 and Pax7 during mouse myogenesis.
Horst D; Ustanina S; Sergi C; Mikuz G; Juergens H; Braun T; Vorobyov E
Int J Dev Biol; 2006; 50(1):47-54. PubMed ID: 16323077
[TBL] [Abstract][Full Text] [Related]
29. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
30. TBX2 expression is regulated by PAX3 in the melanocyte lineage.
Liu F; Cao J; Lv J; Dong L; Pier E; Xu GX; Wang RA; Xu Z; Goding C; Cui R
Pigment Cell Melanoma Res; 2013 Jan; 26(1):67-77. PubMed ID: 23020925
[TBL] [Abstract][Full Text] [Related]
31. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
[TBL] [Abstract][Full Text] [Related]
32. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
33. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
34. A histopathological classification system of Tyr::NRAS
Sohier P; Legrand L; Aktary Z; Grill C; Delmas V; Bernex F; Reyes-Gomez E; Larue L; Vergier B
Pigment Cell Melanoma Res; 2018 May; 31(3):423-431. PubMed ID: 29224244
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells.
Lin CC; Yang CH; Lin YJ; Chiu YW; Chen CY
Enzyme Microb Technol; 2015 Jan; 68():1-9. PubMed ID: 25435499
[TBL] [Abstract][Full Text] [Related]
36. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.
Filimon A; Zurac SA; Milac AL; Sima LE; Petrescu SM; Negroiu G
Melanoma Res; 2014 Jun; 24(3):219-36. PubMed ID: 24709887
[TBL] [Abstract][Full Text] [Related]
37. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
38. Cre reporter mouse expressing a nuclear localized fusion of GFP and beta-galactosidase reveals new derivatives of Pax3-expressing precursors.
Stoller JZ; Degenhardt KR; Huang L; Zhou DD; Lu MM; Epstein JA
Genesis; 2008 Apr; 46(4):200-4. PubMed ID: 18395835
[TBL] [Abstract][Full Text] [Related]
39. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
Colombino M; Capone M; Lissia A; Cossu A; Rubino C; De Giorgi V; Massi D; Fonsatti E; Staibano S; Nappi O; Pagani E; Casula M; Manca A; Sini M; Franco R; Botti G; Caracò C; Mozzillo N; Ascierto PA; Palmieri G
J Clin Oncol; 2012 Jul; 30(20):2522-9. PubMed ID: 22614978
[TBL] [Abstract][Full Text] [Related]
40. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
